Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral Suspension

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 5, 2016

Primary Completion Date

February 27, 2016

Study Completion Date

February 27, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

Apremilast Tablet

30 mg tablet

DRUG

Apremilast Oral Suspension

30 mg oral suspension

Trial Locations (1)

Covance Clinical Research Unit Inc, Madison